ASX Announcement

Clinitrials to lead multi-site Phase 3 trial for EMD-RX5

Published: 13/04/22, 09:22am (AEST)3 pages
Emyria Limited
EMD:ASXHealthcare

Recent EMD Announcements

Price Sensitive only